Your browser doesn't support javascript.
loading
Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective study.
Scharl, Sophia; Zamboglou, Constantinos; Strouthos, Iosif; Farolfi, Andrea; Serani, Francesca; Lanzafame, Helena; Giuseppe Morganti, Alessio; Trapp, Christian; Koerber, Stefan A; Debus, Jürgen; Peeken, Jan C; Vogel, Marco M E; Vrachimis, Alexis; Spohn, Simon K B; Ruf, Juri; Grosu, Anca-Ligia; Ceci, Francesco; Fendler, Wolfgang P; Bartenstein, Peter; Kroeze, Stephanie G C; Guckenberger, Matthias; Krafcsik, Manuel; Klopscheck, Christina; Fanti, Stefano; Hruby, George; Emmett, Louise; Belka, Claus; Stief, Christian; Schmidt-Hegemann, Nina-Sophie; Henkenberens, Christoph; Mayer, Benjamin; Miksch, Jonathan; Shelan, Mohamed; Aebersold, Daniel M; Thamm, Reinhard; Wiegel, Thomas.
Afiliación
  • Scharl S; Department of Radiation Oncology, University Hospital Ulm, Germany. Electronic address: Sophia.scharl@uniklinik-ulm.de.
  • Zamboglou C; Department of Radiation Oncology, Medical Center -Faculty of Medicine, University of Freiburg, Germany; German Cancer Consortium (DKTK), Partner Site Freiburg, Germany; Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Germany; German Oncology Center, University Hospital of th
  • Strouthos I; Department of Radiation Oncology, German Oncology Center, University Hospital of the European University, Limassol, Cyprus.
  • Farolfi A; Division of Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Serani F; Division of Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Lanzafame H; Division of Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Radiation Oncology, Royal North Shore Hospital - University of Sydney, Australia.
  • Giuseppe Morganti A; Division of Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Trapp C; Department of Radiation Oncology, University Hospital, LMU Munich, Germany.
  • Koerber SA; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center, Heidelberg, Germany.
  • Debus J; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center, Heidelberg, Germany.
  • Peeken JC; Department of Radiation Oncology, Klinikum Rechts der Isar, Technical University of Munich (TUM), Germany; Institute of Radiation Medicine (IRM), Department of Radiation Sciences (DRS), Helmholtz Zentrum, München, Germany; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site M
  • Vogel MME; Department of Radiation Oncology, Klinikum Rechts der Isar, Technical University of Munich (TUM), Germany; Institute of Radiation Medicine (IRM), Department of Radiation Sciences (DRS), Helmholtz Zentrum, München, Germany; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site M
  • Vrachimis A; Department of Nuclear Medicine, German Oncology Center, University Hospital of the European University, Limassol, Cyprus; C.A.R.I.C. Cancer Research & Innovation Center, Limassol, Cyprus.
  • Spohn SKB; Department of Radiation Oncology, Medical Center -Faculty of Medicine, University of Freiburg, Germany; German Cancer Consortium (DKTK), Partner Site Freiburg, Germany; Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Germany.
  • Ruf J; German Cancer Consortium (DKTK), Partner Site Freiburg, Germany; Department of Nuclear Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
  • Grosu AL; Department of Radiation Oncology, Medical Center -Faculty of Medicine, University of Freiburg, Germany; German Cancer Consortium (DKTK), Partner Site Freiburg, Germany.
  • Ceci F; Division of Nuclear Medicine, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Fendler WP; Department of Nuclear Medicine, University Hospital, LMU Munich, Germany; Department of Nuclear Medicine, University Hospital Essen, Essen, Germany.
  • Bartenstein P; Department of Radiation Oncology, University Hospital Zürich, University of Zurich, Switzerland.
  • Kroeze SGC; Department of Radiation Oncology, University Hospital Ulm, Germany; Radiation Oncology Center KSA-KSB, Canton Hospital of Aarau, Aarau, Switzerland.
  • Guckenberger M; Department of Radiation Oncology, University Hospital Ulm, Germany.
  • Krafcsik M; Department of Radiation Oncology, University Hospital Ulm, Germany.
  • Klopscheck C; University Hospital Ulm, Ulm, Germany.
  • Fanti S; Division of Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Hruby G; Department of Radiation Oncology, Royal North Shore Hospital - University of Sydney, Australia.
  • Emmett L; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital Sydney Australia; St Vincent's Clinical School, University of New South Wales, Sydney, Australia.
  • Belka C; Department of Radiation Oncology, University Hospital, LMU Munich, Germany.
  • Stief C; Department of Urology, University Hospital, LMU Munich, Germany.
  • Schmidt-Hegemann NS; Department of Radiation Oncology, University Hospital, LMU Munich, Germany.
  • Henkenberens C; Department of Radiotherapy and Special Oncology, Medical School Hannover, Hannover, Germany.
  • Mayer B; Institute for Epidemiology and Medical Biometry, University Ulm, Ulm, Germany.
  • Miksch J; Department of Nuclear Medicine, University Hospital Ulm, University Ulm, Ulm, Germany.
  • Shelan M; Department of Radiation Oncology, Inselspital Bern, University of Bern, Switzerland.
  • Aebersold DM; Department of Radiation Oncology, Inselspital Bern, University of Bern, Switzerland.
  • Thamm R; Department of Radiation Oncology, University Hospital Ulm, Germany.
  • Wiegel T; Department of Radiation Oncology, University Hospital Ulm, Germany.
Radiother Oncol ; 184: 109678, 2023 07.
Article en En | MEDLINE | ID: mdl-37146766
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antígeno Prostático Específico Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Límite: Humans / Male Idioma: En Revista: Radiother Oncol Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Antígeno Prostático Específico Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Límite: Humans / Male Idioma: En Revista: Radiother Oncol Año: 2023 Tipo del documento: Article